To summarize, the APP transgene exerted stronger effects on gene expression than did Arg1 haploinsufficiency, mostly by increasing transcriptomic pathways associated with the risk of neurodegeneration diseases (AD causal risk/disease association) and neuroinflammation (activated microglia/cytokines). This evidence concerns the gene ARG1 and Alzheimer disease.